Physiomics Plc Share Price London S.E.
Equities
GB00B04QT956
Professional Information Services
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
14/06 | Physiomics Plc Adds Modeling and Data Science Functionality to DoseMe's Precision Dosing Platform | CI |
13/06 | Physiomics Secures Virtual Tumor Platform Contract | MT |
Sales 2024 * | 6L 8L 6.62Cr | Sales 2025 * | - | Capitalization | 16.26L 20.59L 17Cr |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - | EV / Sales 2024 * | 2.31 x |
Net cash position 2024 * | 2L 2L 1.91Cr | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.67
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.74% |
Latest transcript on Physiomics Plc
Managers | Title | Age | Since |
---|---|---|---|
Peter Sargent
CEO | Chief Executive Officer | - | 05/23/05 |
Jim Millen
CHM | Chairman | 55 | 18/16/18 |
Director of Finance/CFO | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Corn
BRD | Director/Board Member | 73 | 01/22/01 |
Shalabh Kumar
BRD | Director/Board Member | - | 01/22/01 |
Jim Millen
CHM | Chairman | 55 | 18/16/18 |
1st Jan change | Capi. | |
---|---|---|
+1.88% | 14TCr | |
+18.45% | 7.56TCr | |
+20.12% | 3.92TCr | |
-13.59% | 3.87TCr | |
-3.97% | 2.94TCr | |
-12.13% | 1.6TCr | |
+9.01% | 1.45TCr | |
+8.16% | 1.03TCr | |
-22.56% | 401.1Cr |